Table 2

Drug related problems in type 2 diabetes patients with hypertension (nā€‰=ā€‰387)
Code Problems* Number of problem (Percentage, %)
P1 Adverse reactions 25 (6.5)
P1.1 Side effects suffered (non-allergic) 25 (6.5)
P2 Drug choice problems 87 (22.5)
P2.1 Inappropriate drug (not most appropriate for indication) 34 (8.8)
P2.2 Inappropriate drug form (not most appropriate for indication) 4 (1.0)
P2.3 Inappropriate duplication of therapeutic group or active ingredient 4 (1.0)
P2.4 Contraindication for drug 29 (7.5)
P2.5 No clear indication for drug use 1 (0.3)
P2.6 No drug but clear indication 15 (3.9)
P3 Dosing problems 62 (16.0)
P3.1 Drug dose too low or dosage regime not frequent enough 5 (1.3)
P3.2 Drug dose too high or dosage regime too frequent 44 (11.3)
P3.3 Duration of treatment too short 8 (2.1)
P3.4 Duration of treatment too long 5 (1.3)
P4 Drug use problems 50 (12.9)
P4.1 Drug not taken/administered at all 50 (12.9)
P5 Interactions 63 (16.3)
P5.1 Potential interaction 63 (16.3)
P6 Others 100 (25.8)
P6.1 Patient dissatisfied with therapy despite taking drug(s) correctly 5 (1.3)
P6.2 Insufficient awareness of health and diseases (possibly leading to future problems) 90 (23.2)
P6.4 Therapy failure (reason unknown) 5 (1.3)

*Only problems that have a frequency of more than one were included.

Zaman Huri and Fun Wee

Zaman Huri and Fun Wee BMC Endocrine Disorders 2013 13:2   doi:10.1186/1472-6823-13-2

Open Data